Sanofi-Aventis S.A. ADR (SNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 13,820,500 | 11,647,650 | 11,660,340 | 11,876,140 | 13,232,590 |
| Cost of Goods | 4,180,544 | 3,563,427 | 3,304,999 | 3,879,883 | 3,858,583 |
| Gross Profit | 9,639,959 | 8,084,226 | 8,355,346 | 7,996,258 | 9,374,011 |
| Operating Expenses | 6,138,030 | 6,045,605 | 5,680,357 | 5,910,148 | 5,065,792 |
| Operating Income | 3,502,472 | 2,039,047 | 2,675,986 | 2,086,994 | 4,308,802 |
| Interest Expense | 346,111 | 220,261 | 180,331 | 153,605 | 103,742 |
| Other Income | 218,767 | 54,521 | 153,497 | 2,311,741 | -1,505,764 |
| Pre-tax Income | 3,375,128 | 1,873,307 | 2,649,152 | 4,245,131 | 2,699,296 |
| Income Tax | 612,769 | 295,498 | 492,691 | 962,159 | 605,327 |
| Net Income Continuous | 2,762,359 | 1,577,809 | 2,156,461 | 3,282,972 | 2,093,969 |
| Minority Interests | 14,149 | 13,085 | 15,028 | 59,169 | 3,022 |
| Net Income | $2,748,210 | $1,564,724 | $2,141,433 | $3,223,803 | $2,090,947 |
| EPS Basic Total Ops | 1.10 | 0.63 | 0.86 | 1.28 | 0.84 |
| EPS Basic Continuous Ops | 1.10 | 0.63 | 0.86 | 1.31 | 0.84 |
| EPS Diluted Total Ops | 1.10 | 0.63 | 0.86 | 1.27 | 0.84 |
| EPS Diluted Continuous Ops | 1.10 | 0.63 | 0.86 | 1.30 | 0.84 |
| EBITDA(a) | $3,502,472 | $2,039,047 | $2,675,986 | $2,086,996 | $4,308,802 |